Subsidies. Love ’em or hate them, they dominated the news during the Affordable Care Act’s sign-up season, and their reduction is now hitting many enrollees in the pocketbook. While lawmakers continue to disagree on a way forward, and the politics of affordability keeps the issue front and center, it would be understandable to think these…
Frist Cressey Ventures closed a $425 million fourth fund to invest in early-stage healthcare companies using AI to improve care, reduce costs and support the aging population. The post What Frist Cressey Ventures Will Target With Its $425M Healthcare Fund appeared first on MedCity News.
Danaher is acquiring Masimo in a $10 billion deal aimed at expanding its diagnostics portfolio and deepening its presence in acute care settings. The move reflects a broader industry shift toward consolidation and integrated care, as large healthcare companies seek scale and more continuous clinical data inside hospitals. The post Danaher Drops $10B to Snatch…
By DAVID SHAYWITZ “There are decades where nothing happens; and there are weeks where decades happen,” said Lenin, probably never. It’s also a remarkably apt characterization of the last year in generative AI (genAI) — the last week in particular — which has seen the AI landscape shift so dramatically that even skeptics are now updating…
Novartis’s alliance with Unnatural Products is pursuing next-generation peptide drugs for cardiovascular disease. The startup already has drug R&D alliances with BridgeBio Pharma, Merck, and Argenx. The post Novartis Commits $100M to Startup With Tech That Brings Peptides to Undruggable Targets appeared first on MedCity News.
Startup has expanded its Care+ home visits across lines of business to Medicare, Medicaid and Marketplace
The Host Mary Agnes Carey KFF Health News @maryagnescarey Read Mary Agnes’ stories. The midterm elections are months away, yet changes at the Department of Health and Human Services suggest the Trump administration is focusing on how to win on health care, which remains a top concern for voters. Facing growing concern about the administration’s…
Rising denial rates of 10-15 percent are depleting hospital cash reserves and increasing financial strain on healthcare providers
Intrauterine devices (IUDs), along with implants, are known as long-acting reversible contraception (LARCs) because they can be used to prevent pregnancy for several years. This fact sheet reviews FDA-approved IUDs, as well as use, availability, and key issues in insurance coverage and financing of IUDs in the U.S.